Aerobic Granular Sludge (AGS) has emerged as one of the most promising alternatives to Conventional Activated Sludge (CAS) for municipal wastewater treatment due to its excellent settling characteristics, compact footprint, reduced energy demand, and ability to achieve simultaneous carbon, nitrogen, and phosphorus removal within a single reactor. Although AGS has reached commercial application in sequencing batch reactor (SBR) systems, its widespread implementation remains limited by several technical and operational challenges, particularly in continuous-flow configurations. This review provides a critical assessment of the engineering barriers restricting the broader adoption of AGS at full scale. This work integrates the current understanding of granule formation and pollutant removal with a comprehensive evaluation of full-scale implementation challenges, including reactor configuration, start-up time, granule stability, influent variability, oxygen transfer limitations, retrofit feasibility, and techno-economic considerations. Potential solutions such as hydrocyclones, selectors, bioaugmentation, carrier-assisted granulation, and optimized reactor configurations are reviewed. The review critically compares SBR and continuous-flow AGS technologies, highlighting the advantages, limitations, and technological maturity of each configuration based on published full-scale and near full-scale experiences. The analysis indicates that while SBR-based AGS has demonstrated reliable full-scale performance and commercial maturity, continuous-flow AGS still requires significant technological development to achieve comparable granulation stability and operational robustness. Finally, future research priorities are identified, including resilient continuous-flow reactor configurations, advanced process control, integrated techno-economic and life-cycle assessments, and enhanced resource recovery strategies to facilitate the wider implementation of AGS technology in municipal wastewater treatment.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: